Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Careers | Investor Relations | News & Media | Events | KCI Recycling | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education and Training  |  For Patients  |  Customer Support  |  Suppliers
You are here: Home > Products > Negative Pressure Technology Platform > V.A.C.® Therapy > V.A.C. Therapy System Fact Sheet
Print

V.A.C. Therapy System Fact Sheet

Overview

KCI's proprietary V.A.C.® Therapy System has revolutionized the way in which caregivers treat the most serious, complex wounds. V.A.C. Therapy utilizes an open-cell polymer foam dressing that is conformed to the wound bed. When sealed and placed under negative (vacuum) pressure, the system creates a unique wound healing environment that has been shown to promote the wound healing process, reduce edema, prepare the wound bed for closure, promote the formation of granulation tissue and remove infectious materials.

 

 

V.A.C. Therapy System Illustration

 

 

History

In 1996, KCI introduced this innovative approach to the treatment of serious, complex wounds through the use of sub-atmospheric or negative pressure. Known today as “negative pressure wound therapy” (NPWT), KCI’s proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy System has revolutionized the advanced wound care market and remains the most clinically proven alternative for the treatment of complex, hard-to-heal wounds.

Product Portfolio

The InfoV.A.C.® System (on left) is a wound healing therapy system designed for patients in the acute care setting.  

The ActiV.A.C.® System (on right) is designed for ambulatory patients and is used primarily in the home care setting.

 

 

VAC duo

 

 

The ABThera (image below) Open Abdomen Negative Pressure Therapy System addresses patient quality of life through an easy-to-use system designed to assist surgeons in the management and treatment of “open abdomen” and to help achieve primary fascial closure.

 

 

Abthera

 

 

 

Research and Development (R&D)

KCI continues to invest in innovation with an ongoing commitment to research and development aimed at improving patient outcomes while reducing the overall cost of care. In 2008, KCI invested more than $76 million in its R&D efforts, which are led by approximately 240 clinical research and development professionals.

Clinical Distinction

V.A.C.® Therapy is recognized as a significant, clinically proven advancement in wound care that promotes active wound healing at the cellular level utilizing three vital V.A.C. Therapy components:

  • The proprietary V.A.C.® GranuFoam Dressing means the difference between healing and simply draining a wound. GranuFoam Dressings provide increased metabolic activity and evenly distributes vacuum pressure at the wound surface, creating the angiogenesis and cell proliferation necessary for wound healing. Gauze-based negative pressure wound therapy devices only drain the wound. The technology of GranuFoam Dressings also allows the dressing to adapt to the contours of deep or unevenly shaped wounds.
  • The technology of SensaT.R.A.C. Dressings regulates pressure at the wound site to ensure patients receive the prescribed amount of negative pressure for optimal healing.
  • The V.A.C.® Therapy unit utilizes sophisticated software algorithms to provide intermittent and continuous negative pressure to the wound.
     

V.A.C. Therapy at a Glance

Wounds Treated 8 million worldwide*
Units Manufactured 42,000
Key Relationships Globally 21,000 hospitals and skilled nursing facilities
11,000 home health agencies
Caregivers Trained (Continuing Education) Accredited training for caregivers in all care settings.
Customer Support 1,000+ member clinical sales team
24x7x365 Customer and Patient Support
Over 690,000 customers self-served in 2008 utilizing KCI Express®

* As of 12/31/13 KCI data on file

Clinical Study Support

KCI’s V.A.C. Therapy System enjoys an unprecedented body of clinical evidence that demonstrates clinical efficacy and cost-effectiveness, with:

  • 41 Randomized Clinical Trials (RCTs)
  • More than 918 Peer Reviewed Articles
  • More than 931 Abstracts
  • 71 Medical Text Book Citations

FOR MORE INFORMATION, CONTACT:

Kinetic Concepts, Inc.
Media Relations:
Media@kci1.com for journalists only.

Updated: 12 May 2014


  • KCI Express
  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Terms of Use | Privacy Policy | Contact Us | News Feed


Copyright © 1998 - 2013 KCI Licensing, Inc. All Rights Reserved.    DSL# 09-03-193
The information included in this Web site has been prepared for and is intended for viewing exclusively within the United States of America. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.